Alzai Health Corp. ALZI.V
TSX
| 07/31/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 459.33% | -- | |||
| Gross Profit | -315.31% | -- | |||
| SG&A Expenses | 40.17% | 254.49% | |||
| Depreciation & Amortization | 42.31% | 3,000.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 70.80% | 398.21% | |||
| Operating Income | -63.44% | -389.25% | |||
| Income Before Tax | -81.79% | -383.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -81.79% | -383.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -81.79% | -383.53% | |||
| EBIT | -63.44% | -389.25% | |||
| EBITDA | -64.21% | -389.51% | |||
| EPS Basic | -45.12% | -80.91% | |||
| Normalized Basic EPS | -44.23% | -79.71% | |||
| EPS Diluted | -45.12% | -80.91% | |||
| Normalized Diluted EPS | -44.23% | -79.71% | |||
| Average Basic Shares Outstanding | 25.44% | 167.08% | |||
| Average Diluted Shares Outstanding | 25.44% | 167.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||